Health AI Central
Share:
Peer-Reviewed Publication
Front Public Health2025;131723829.January 1, 2025Journal Article

Economic value of AI-based MRI triage for Parkinson's disease: a cost-benefit study in South Korea and the United States.

KyungYi Kim1, Soohwa Song2, Sung Sik Kim3, Dong Hoon Shin2, A-Leum Lee4
1Department of Biohealth Industry, Graduate School of Transdisciplinary Health Sciences, Yonsei University, Seoul, Republic of Korea.
2Heuron Co., Ltd., Seoul, Republic of Korea.
3Severance Hospital, Seoul, Republic of Korea.
4Department of Radiology, Soonchunhyang University Hospital Bucheon, Bucheon-si, Gyeonggi-do, Republic of Korea.
PubMed PMC DOI PDF

Abstract

BACKGROUND: Early and accurate diagnosis of Parkinson's disease (PD) remains a major clinical and economic challenge, particularly in settings where dopaminergic imaging, such as positron emission tomography (PET) scans, is limited by cost, availability, and patient access. Artificial intelligence (AI) has emerged as a promising tool to support magnetic resonance imaging (MRI)-based diagnosis of P…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.